Immuneering Corp (IMRX) stock news · $124.2M cap
Immuneering Corp (IMRX) is a biotechnology company listed on US.
This IMRX news page leads with what Immuneering Corp filed — not a scraped headline mill.
No cached 8-K sentence for IMRX yet. We will not pad this page with generic market recap.
Latest reported IMRX revenue for 2023-12-31 was $0. Net income was -$53.5M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. IMRX currently screens at market cap $124.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the IMRX stock page; for the tape open the quote page.
IMRX stock news FAQ
What is IMRX's latest net income?
Latest cached Immuneering Corp (IMRX) net income was -$53.5M. Statements: https://lician.com/financials/imrx
What is IMRX's market cap?
Immuneering Corp (IMRX) market cap is $124.2M on the latest cached fundamentals snapshot.
What kind of company is IMRX?
Immuneering Corp (IMRX) is a biotechnology company listed on US.
Where is IMRX stock news listed?
Cached stock news for Immuneering Corp (IMRX) is listed at https://lician.com/news/imrx. Filings: https://lician.com/sec/imrx
Not investment advice.